US 12,290,557 B2
Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
Jacqueline Gayle Marx, Portage, MI (US); John Morgan Hardham, Kalamazoo, MI (US); Paul J. Dominowski, Kalamazoo, MI (US); Vicki Jon Rapp Gabrielson, Kalamazoo, MI (US); Monica Balasch Sanuy, Barcelona (ES); Marta Cabana Sumsi, Barcelona (ES); Laia Plaja Dilmé, Girona (ES); Alicia Urniza Hostench, Girona (ES); and Oscar Romero Galindo, White Plains, NY (US)
Assigned to Zoetis Services LLC, Parsippany, NJ (US)
Filed by Zoetis Services LLC, Parsippany, NJ (US)
Filed on Feb. 17, 2021, as Appl. No. 17/177,724.
Application 17/177,724 is a continuation of application No. 16/282,953, filed on Feb. 22, 2019, granted, now 10,953,088.
Application 16/282,953 is a continuation of application No. 15/324,908, granted, now 10,251,950, issued on Apr. 9, 2019, previously published as PCT/US2015/039475, filed on Jul. 8, 2015.
Claims priority of provisional application 62/143,412, filed on Apr. 6, 2015.
Claims priority of provisional application 62/121,193, filed on Feb. 26, 2015.
Claims priority of provisional application 62/115,806, filed on Feb. 13, 2015.
Claims priority of provisional application 62/102,712, filed on Jan. 13, 2015.
Claims priority of provisional application 62/093,657, filed on Dec. 18, 2014.
Claims priority of provisional application 62/046,256, filed on Sep. 5, 2014.
Claims priority of provisional application 62/037,403, filed on Aug. 14, 2014.
Claims priority of provisional application 62/023,302, filed on Jul. 11, 2014.
Prior Publication US 2024/0226270 A1, Jul. 11, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/215 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01)
CPC A61K 39/215 (2013.01) [A61K 39/12 (2013.01); C12N 7/00 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/575 (2013.01); A61K 2039/70 (2013.01); C12N 2770/20022 (2013.01); C12N 2770/20034 (2013.01); C12N 2770/20063 (2013.01); C12N 2770/20071 (2013.01)] 6 Claims
 
1. A vaccine composition comprising inactivated porcine epidemic diarrhea virus (PEDV), adjuvanted as an oil-in-water emulsion, wherein the adjuvant components include de-oiled lecithin dissolved in a light mineral oil and aluminum hydroxide, wherein said vaccine, upon administration to a swine, elicits production of neutralizing antibodies in the swine.